CMV antiviral stewardship in transplantation – the next frontier

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

(2023) Ajit P. Limaye et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients

(2023) Toshihiro Matsui et al.   CURRENT OPINION IN INFECTIOUS DISEASES

First RSV vaccine approvals

(2023) Priya Venkatesan   Lancet Microbe

Outbreak of Respiratory Syncytial Virus Bronchiolitis in Italy

(2022) Giuseppe Indolfi et al.   CLINICAL INFECTIOUS DISEASES

Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies

(2022) Ami Vyas et al.   Open Forum Infectious Diseases

Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: Likely role of lower transmission in the community

(2021) Fernanda Hammes Varela et al.   Journal of Global Health

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial

(2021) Robin K Avery et al.   CLINICAL INFECTIOUS DISEASES

Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection

(2020) Sunwen Chou et al.   JOURNAL OF INFECTIOUS DISEASES

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE